Home > Boards > US Listed > Biotechs > RedHill Biopharma Ltd. (RDHL)

U.S. FDA approves RedHill's bacterial infection treatment

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
noretreat Member Profile
 
Followed By 120
Posts 11,751
Boards Moderated 2
Alias Born 01/06/10
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/18/2020 7:02:33 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/13/2020 9:56:32 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/27/2020 4:28:04 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/27/2020 7:01:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/21/2020 7:15:44 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/2/2020 9:00:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/17/2019 8:01:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/21/2019 8:00:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/20/2019 7:00:59 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/19/2019 7:01:09 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/15/2019 8:01:05 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/13/2019 7:00:57 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/12/2019 7:01:02 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 11/6/2019 2:35:27 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/4/2019 6:06:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/29/2019 8:01:26 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/28/2019 9:04:03 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/18/2019 6:02:07 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/16/2019 8:01:29 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/11/2019 9:01:09 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/30/2019 6:31:05 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/26/2019 8:00:53 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/27/2019 7:01:19 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 8/21/2019 7:01:01 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 8/9/2019 6:00:55 AM
noretreat   Monday, 11/04/19 09:16:33 AM
Re: None
Post # of 1826 
U.S. FDA approves RedHill's bacterial infection treatment
REUTERS 5:38 AM ET 11/4/2019

Nov 4 (Reuters) - RedHill Biopharma Ltd's(RDHL) said on Monday its three-drug combination therapy to treat Helicobacter pylori bacterial infections had been approved by the U.S. Food and Drug Administration.

The drug, Talicia, is an oral capsule comprising two antibiotics, amoxicillin and rifabutin, as well as omeprazole, a common treatment for heartburn.

The Israel-based company said the drug was designed to address the high resistance of H. pylori bacteria to current clarithromycin-based standard-of-care therapies.

RedHill expects to launch Talicia in the United States in the first quarter next year.

Helicobacter pylori infection affects over 50% of the population worldwide, according to Redhill, and is one of the strongest risk factors in the development of gastric cancer. (Reporting by Manas Mishra in Bengaluru; Editing by Anil D'Silva and Shinjini Ganguli)

(c) Copyright Thomson Reuters 2019. Click For Restrictions - https://agency.reuters.com/en/copyright.html

No Retreat ... No Surrender
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist